{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:41:33Z","timestamp":1780735293835,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ypmed.2024.107984","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T16:08:07Z","timestamp":1714752487000},"page":"107984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Association between autoimmune liver diseases and chronic hepatitis B: A multivariable Mendelian randomization study in European population"],"prefix":"10.1016","volume":"184","author":[{"given":"Wenhui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2024.107984_bb0005","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJM199912303412707","article-title":"Molecular mimicry and autoimmunity","volume":"341","author":"Albert","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2024.107984_bb0010","doi-asserted-by":"crossref","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","article-title":"Effects of tobacco smoke on immunity, inflammation and autoimmunity","volume":"34","author":"Arnson","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ypmed.2024.107984_bb0015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12325-021-01983-5","article-title":"May previous hepatitis B virus infection be involved in etiology and pathogenesis of autoimmune liver diseases?","volume":"39","author":"Batskikh","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ypmed.2024.107984_bb0020","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.autrev.2018.06.008","article-title":"IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases","volume":"17","author":"Beringer","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ypmed.2024.107984_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102534","article-title":"The role of complement activation in autoimmune liver disease","volume":"19","author":"Biewenga","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ypmed.2024.107984_bb0030","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/apt.16751","article-title":"Editorial: testing for Epstein-Barr virus and treating autoimmune hepatitis-still a long way to go!","volume":"55","author":"Bolia","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ypmed.2024.107984_bb0035","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review","volume":"10","author":"Bowden","year":"2019","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.ypmed.2024.107984_bb0040","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/ije\/dyt093","article-title":"Use of allele scores as instrumental variables for Mendelian randomization","volume":"42","author":"Burgess","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","author":"Carbone","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation","volume":"36","author":"Carter","year":"2021","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0055","series-title":"IL-21, Not IL-17A, Exacerbates Murine Primary Biliary Cholangitis. Clinical and Experimental Immunology","author":"Chan","year":"2023"},{"key":"10.1016\/j.ypmed.2024.107984_bb0060","article-title":"Life factors acting on systemic lupus erythematosus","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0065","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0168-8278(05)80279-X","article-title":"Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States","volume":"18","author":"Czaja","year":"1993","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jhep.2014.09.010","article-title":"Unmet clinical need in autoimmune liver diseases","volume":"62","author":"Dyson","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0075","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00281-022-00950-8","article-title":"How genetic risk contributes to autoimmune liver disease","volume":"44","author":"Ellinghaus","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0080","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian Randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.ypmed.2024.107984_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2018.10.014","article-title":"Extrahepatic autoimmunity in autoimmune liver disease","volume":"59","author":"Floreani","year":"2019","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ypmed.2024.107984_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899372","article-title":"Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes","volume":"13","author":"Frazzei","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0095","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1478-3231.2008.01851.x","article-title":"Occult hepatitis B virus infection in patients with autoimmune liver diseases","volume":"29","author":"Georgiadou","year":"2009","journal-title":"Liver international\u202f: official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.ypmed.2024.107984_bb0100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/hep.510240309","article-title":"Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa","volume":"24","author":"Gregorio","year":"1996","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.ypmed.2024.107984_bb0105","first-page":"1802","article-title":"Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection","volume":"162","author":"Gregorio","year":"1999","journal-title":"J. Immunol. (Baltimore, Md.\u202f: 1950)"},{"key":"10.1016\/j.ypmed.2024.107984_bb0110","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ije\/dyu045","article-title":"Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort","volume":"43","author":"Harps\u00f8e","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173820","article-title":"Usefulness of clinical and laboratory criteria for diagnosing autoimmune liver disease among patients with systemic lupus erythematosus: an observational study","volume":"10","author":"Heijke","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ypmed.2024.107984_bb0120","article-title":"Mendelian randomization study of ACLY and cardiovascular disease","volume":"383","author":"H\u00f3lm","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2024.107984_bb0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41423-020-00568-6","article-title":"Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease","volume":"18","author":"Horst","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0130","first-page":"11","article-title":"Smoking under hypoxic conditions: a potent environmental risk factor for inflammatory and autoimmune diseases","volume":"5","author":"Hussain","year":"2018","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.ypmed.2024.107984_bb0135","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ypmed.2024.107984_bb0140","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.21037\/apm-23-250","article-title":"Management of autoimmune and viral hepatitis in immunotherapy: a narrative review","volume":"12","author":"Kuo","year":"2023","journal-title":"Annals of Palliative Med."},{"key":"10.1016\/j.ypmed.2024.107984_bb0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.clim.2016.10.006","article-title":"Crosstalk between the gut and the liver via susceptibility loci: novel advances in inflammatory bowel disease and autoimmune liver disease","volume":"175","author":"Li","year":"2017","journal-title":"Clinical Immunol. (Orlando, Fla.)"},{"key":"10.1016\/j.ypmed.2024.107984_bb0150","article-title":"NK cells in autoimmune diseases: protective or pathogenic?","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0155","first-page":"527","article-title":"Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients","volume":"33","author":"Lohse","year":"1995","journal-title":"Z. Gastroenterol."},{"issue":"Suppl. 2","key":"10.1016\/j.ypmed.2024.107984_bb0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2893.1997.tb00179.x","article-title":"Viral induction of autoimmunity: mechanisms and examples in hepatology","volume":"4","author":"Manns","year":"1997","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.ypmed.2024.107984_bb0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","article-title":"Hepatitis B virus (HBV) and autoimmune disease","volume":"34","author":"Maya","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0170","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5114\/ada.2023.129308","article-title":"A crossroads between dietary habits, alcohol consumption, and smoking in the clinical course of psoriasis: a narrative review","volume":"40","author":"Michalski","year":"2023","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0175","first-page":"246","article-title":"Antiviral immune responses: triggers of or triggered by autoimmunity? Nature reviews","volume":"9","author":"M\u00fcnz","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.ypmed.2024.107984_bb0180","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2169\/internalmedicine.35.468","article-title":"Hepatitis B virus carrier status linked to autoimmune hepatitis","volume":"35","author":"Murakami","year":"1996","journal-title":"Internal Med. (Tokyo, Japan)"},{"key":"10.1016\/j.ypmed.2024.107984_bb0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/apt.16708","article-title":"Epstein-Barr virus status and immunosuppression use in paediatric autoimmune liver disease","volume":"55","author":"Nayagam","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ypmed.2024.107984_bb0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1074-7613(01)00172-8","article-title":"Analysis of the relationship between viral infection and autoimmune disease","volume":"15","author":"Panoutsakopoulou","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.ypmed.2024.107984_bb0195","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamapsychiatry.2020.3946","article-title":"Association between physical activity and schizophrenia: results of a 2-sample Mendelian randomization analysis","volume":"78","author":"Papiol","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ypmed.2024.107984_bb0200","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.autrev.2008.06.008","article-title":"The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders","volume":"7","author":"Ram","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ypmed.2024.107984_bb0205","first-page":"173","article-title":"Assessment of the possible impact of hepatitis viruses on the development and course of autoimmune liver diseases","volume":"95","author":"Sbikina","year":"2023","journal-title":"Ter. Arkh."},{"key":"10.1016\/j.ypmed.2024.107984_bb0210","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data","volume":"27","author":"Sekula","year":"2016","journal-title":"J. American Soc.Nephrol.\u202f: JASN"},{"key":"10.1016\/j.ypmed.2024.107984_bb0215","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/s41467-017-02304-7","article-title":"Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance","volume":"8","author":"Shen","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ypmed.2024.107984_bb0220","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.7150\/thno.35331","article-title":"IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models","volume":"9","author":"Shen","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ypmed.2024.107984_bb0225","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.7150\/thno.44715","article-title":"Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection","volume":"10","author":"Shen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ypmed.2024.107984_bb0230","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ (Clinical Research ed.)"},{"key":"10.1016\/j.ypmed.2024.107984_bb0235","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1373\/clinchem.2009.141564","article-title":"Mendelian randomization in the era of genomewide association studies","volume":"56","author":"Sleiman","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ypmed.2024.107984_bb0240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/1745691610383505","article-title":"Mendelian randomization for strengthening causal inference in observational studies: application to gene \u00d7 environment interactions","volume":"5","author":"Smith","year":"2010","journal-title":"Perspectives on psychological science\u202f: a journal of the Association for Psychological Science"},{"key":"10.1016\/j.ypmed.2024.107984_bb0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1665-2681(19)31481-4","article-title":"Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis","volume":"11","author":"Smyk","year":"2012","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/08916939109001904","article-title":"Genes for interleukin-1, interleukin-6, and tumor necrosis factor are expressed at markedly reduced levels in the livers of patients with severe liver disease","volume":"10","author":"Tovey","year":"1991","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ypmed.2024.107984_bb0255","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/MEG.0b013e328303e1ea","article-title":"Autoimmune hepatitis combined with multiple viral infections","volume":"20","author":"Tseng","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0260","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00281-012-0328-6","article-title":"Autoimmune manifestations in viral hepatitis","volume":"35","author":"Vergani","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0265","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0952-7915(96)80019-7","article-title":"Virus-induced autoimmune disease","volume":"8","author":"von Herrath","year":"1996","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0270","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.antiviral.2012.12.018","article-title":"IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line","volume":"97","author":"Wang","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ypmed.2024.107984_bb0275","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ypmed.2024.107984_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.649376","article-title":"Causal linkage between inflammatory bowel disease and primary Sclerosing cholangitis: a two-sample Mendelian randomization analysis","volume":"12","author":"Xie","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ypmed.2024.107984_bb0285","doi-asserted-by":"crossref","first-page":"1276459","DOI":"10.3389\/fimmu.2023.1276459","article-title":"Genetic link between primary sclerosing cholangitis and thyroid dysfunction: a bidirectional two-sample Mendelian randomization study","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ypmed.2024.107984_bb0290","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/2045-3701-3-46","article-title":"Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17","volume":"3","author":"Zheng","year":"2013","journal-title":"Cell Biosci."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743524001397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743524001397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T04:01:37Z","timestamp":1717214497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743524001397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":58,"alternative-id":["S0091743524001397"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2024.107984","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between autoimmune liver diseases and chronic hepatitis B: A multivariable Mendelian randomization study in European population","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2024.107984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107984"}}